John Bunch, Pmp
About John Bunch, Pmp
John Bunch, PMP, is the Global Business Capability Lead for mHealth Data at Bristol Myers Squibb, with extensive experience in IT, project management, and mHealth innovation.
Company
John Bunch currently works at Bristol Myers Squibb, serving in the role of Global Business Capability Lead, mHealth Data. Bristol Myers Squibb is a global biopharmaceutical company known for focusing on innovative medicines to address severe diseases in patients worldwide. John operates out of the San Diego Metropolitan Area.
Title
John Bunch holds the position of Global Business Capability Lead, mHealth Data at Bristol Myers Squibb. In this role, he drives the governance strategy, roadmap, execution, and monitoring of mHealth initiatives. He also serves as a Subject Matter Expert for mHealth growth, overseeing system and technology evaluation, regulatory inspections, and internal audits.
Education and Expertise
John Bunch pursued his studies at North Carolina State University, where he specialized in Bioinformatics and Computer Science, earning a Bachelor of Science degree. His educational background provides a strong foundation for his work in technology and healthcare innovation. John holds certifications as a Project Management Professional (PMP), Six Sigma, and Prosci Change Management Leader.
Professional Background
John Bunch has over 15 years of experience in CRM, IT-PMO, and contracts management across clinical research organizations (CROs) and federal environments. His career spans multiple roles, including Director of Delivery at THREAD, Associate Director IT Client Engagement Team / Innovation at PPD, and Principal Project Manager Health IT at SRA. He also has experience as a Senior Project Manager at Constella Group and Senior Systems Analyst at IBM Corporation.
Industry Contributions
Throughout his career, John Bunch has focused on implementing and realizing innovations in wearables, remote monitoring, telehealth, and other mHealth technologies. He consults widely on wearable devices and eClinical projects, enhancing research strategies with effective device-centric decentralized trial protocols. His efforts aim to drive the adoption of new technologies within clinical trials and healthcare services, maintaining rigorous standards for legal, privacy, and FDA regulations.